Theriva Biologics Future Growth

How is Theriva Biologics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

0/6

Future Growth Score 0/6

14.1%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

Earnings and Revenue Growth Forecasts

NYSEAM:TOVX - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	N/A	N/A	N/A	N/A	1
12/31/2024	N/A	N/A	N/A	N/A	1
12/31/2023	N/A	N/A	N/A	N/A	1
9/30/2022	N/A	-20	-19	-19	N/A
6/30/2022	N/A	-18	-16	-16	N/A
3/31/2022	N/A	-16	-14	-14	N/A
12/31/2021	N/A	-23	-13	-13	N/A
9/30/2021	N/A	-21	-11	-11	N/A
6/30/2021	N/A	-20	-11	-11	N/A
3/31/2021	N/A	-21	-11	-11	N/A
12/31/2020	N/A	-13	-12	-12	N/A
9/30/2020	N/A	-13	-13	-13	N/A
6/30/2020	N/A	-15	-14	-14	N/A
3/31/2020	N/A	-16	-15	-15	N/A
12/31/2019	N/A	-16	-14	-14	N/A
9/30/2019	N/A	-28	-14	-14	N/A
6/30/2019	N/A	-26	-14	-14	N/A
3/31/2019	N/A	-27	-15	-15	N/A
12/31/2018	N/A	-25	-17	-17	N/A
9/30/2018	N/A	-8	-18	-18	N/A
6/30/2018	N/A	-22	-19	-19	N/A
3/31/2018	N/A	-22	-20	-20	N/A
12/31/2017	N/A	-22	-20	-20	N/A
9/30/2017	N/A	-27	-27	-27	N/A
6/30/2017	N/A	-18	-29	-28	N/A
3/31/2017	N/A	-19	-29	-28	N/A
12/31/2016	N/A	-27	-28	-28	N/A
9/30/2016	N/A	-36	-29	-28	N/A
6/30/2016	N/A	-34	N/A	-38	N/A

Earnings vs Savings Rate: Insufficient data to determine if TOVX's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if TOVX's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if TOVX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TOVX's revenue is forecast to grow faster than the US market.

High Growth Revenue: TOVX is forecast to have no revenue next year.

Future ROE: Insufficient data to determine if TOVX's Return on Equity is forecast to be high in 3 years time